Market Overview:
The global radionuclide scanning services market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in the field of radionuclide scanning services. Based on type, the global radionuclide scanning services market is segmented into diagnosis and prognosis. The diagnosis segment is further sub-segmented into heart blood flow functions, differential lung function, body infections & inflammations, bone fracture & infections, gall bladder & bile duct functions, gastrointestinal bleeding and tumor localization. The prognosis segment is further sub-segmented into health risk assessment and patient management decision support. Based on application, the global radionuclide scanning services market is divided into six segments: heart blood flow functions; differential lung function; body infections & inflammations; bone fracture & infections; gall bladder & bile duct functions; gastrointestinal bleeding and tumor localization.
Product Definition:
A radionuclide scanning service is a medical procedure that uses radioactive materials to create images of the body. This type of imaging can be used to diagnose a variety of conditions, including tumors, heart disease, and infections. Radionuclide scanning services are an important tool for diagnosing and treating many medical conditions.
Diagnosis:
The global diagnosis, it's usage and growth factor in the radionuclide scanning services market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of cancer globally is one of the major factors driving demand for diagnostic imaging techniques such as Computed Tomography (CT), which involve radionuclide scans for diagnosis purposes.
Prognosis:
Prognosis is the science and art of prediction about a disease or medical condition. Prognostic techniques are used to evaluate, detect, and analyze prognosis-related data. The global prognosis scanning services market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period (2016-2021).
Application Insights:
The heart blood flow functions segment dominated the global radionuclide scanning services market in 2017. This is due to a large number of applications for which tracers are used to assess the function of the heart. For instance, cardiologists use radioactive isotopes for imaging and quantification of myocardial perfusion during cardiac surgery or angioplasty procedures. Such factors are anticipated to drive growth over the forecast period.
differential lung function segment is expected to grow at a lucrative rate during the study period owing to rising applications in diagnosis and prognosis of various respiratory disorders such as asthma, COPD, bronchitis, emphysema etcetera. In addition, an increasing number of R&D initiatives by major players for developing new diagnostic techniques using radionuclides is also expected fuel growth over next seven years. Other application segments include bone fracture & infections; body infections & inflammations; gastrointestinal bleeding; tumor localization; and others (urology).
Regional Analysis:
North America dominated the global radionuclide scanning services market in 2017. In addition, increasing R&D investments by pharmaceutical and medical device companies are expected to drive growth during the forecast period. Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to factors such as improving healthcare infrastructure, growing patient awareness levels about available treatment options along with rising disposable income levels in emerging countries like India & China.
The key players operating in this industry include GE Healthcare; Siemens Healthineers; Cisne Nuclear Medicine; Abbott Laboratories; Amgen Inc.; Chugai Pharmaceutical Co.
Growth Factors:
- Increasing incidence of cancer and other diseases that require radionuclide scanning for diagnosis and treatment
- Growing demand for early detection and diagnosis of cancer to improve chances of successful treatment
- Rising number of nuclear medicine physicians and radiologists who are skilled in performing radionuclide scans
- Advances in technology that have made radionuclide scanning more accurate, efficient, and safe
- Increasing awareness among patients about the benefits of radionuclide scanning
Scope Of The Report
Report Attributes
Report Details
Report Title
Radionuclide Scanning Services Market Research Report
By Type
Diagnosis, Prognosis
By Application
Heart Blood Flow Functions, Differential Lung Function, Body Infections & Inflammations, Bone Fracture & Infections, Gall Bladder & Bile Duct Functions, Gastrointestinal Bleeding, Tumor Localization, Others
By Companies
Sonic Healthcare, Aditya Birla Health Services, Alliance Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Radionuclide Scanning Services Market Report Segments:
The global Radionuclide Scanning Services market is segmented on the basis of:
Types
Diagnosis, Prognosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Blood Flow Functions, Differential Lung Function, Body Infections & Inflammations, Bone Fracture & Infections, Gall Bladder & Bile Duct Functions, Gastrointestinal Bleeding, Tumor Localization, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sonic Healthcare
- Aditya Birla Health Services
- Alliance Medical
Highlights of The Radionuclide Scanning Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnosis
- Prognosis
- By Application:
- Heart Blood Flow Functions
- Differential Lung Function
- Body Infections & Inflammations
- Bone Fracture & Infections
- Gall Bladder & Bile Duct Functions
- Gastrointestinal Bleeding
- Tumor Localization
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radionuclide Scanning Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radionuclide scanning services are a type of radiation detection that uses radioactive isotopes to identify objects or materials. This technology is often used in security and environmental monitoring applications.
Some of the key players operating in the radionuclide scanning services market are Sonic Healthcare, Aditya Birla Health Services, Alliance Medical.
The radionuclide scanning services market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radionuclide Scanning Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radionuclide Scanning Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radionuclide Scanning Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radionuclide Scanning Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radionuclide Scanning Services Market Size & Forecast, 2020-2028
4.5.1 Radionuclide Scanning Services Market Size and Y-o-Y Growth
4.5.2 Radionuclide Scanning Services Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnosis
5.2.2 Prognosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Heart Blood Flow Functions
6.2.2 Differential Lung Function
6.2.3 Body Infections & Inflammations
6.2.4 Bone Fracture & Infections
6.2.5 Gall Bladder & Bile Duct Functions
6.2.6 Gastrointestinal Bleeding
6.2.7 Tumor Localization
6.2.8 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radionuclide Scanning Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radionuclide Scanning Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnosis
9.6.2 Prognosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Heart Blood Flow Functions
9.10.2 Differential Lung Function
9.10.3 Body Infections & Inflammations
9.10.4 Bone Fracture & Infections
9.10.5 Gall Bladder & Bile Duct Functions
9.10.6 Gastrointestinal Bleeding
9.10.7 Tumor Localization
9.10.8 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnosis
10.6.2 Prognosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Heart Blood Flow Functions
10.10.2 Differential Lung Function
10.10.3 Body Infections & Inflammations
10.10.4 Bone Fracture & Infections
10.10.5 Gall Bladder & Bile Duct Functions
10.10.6 Gastrointestinal Bleeding
10.10.7 Tumor Localization
10.10.8 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnosis
11.6.2 Prognosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Heart Blood Flow Functions
11.10.2 Differential Lung Function
11.10.3 Body Infections & Inflammations
11.10.4 Bone Fracture & Infections
11.10.5 Gall Bladder & Bile Duct Functions
11.10.6 Gastrointestinal Bleeding
11.10.7 Tumor Localization
11.10.8 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnosis
12.6.2 Prognosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Heart Blood Flow Functions
12.10.2 Differential Lung Function
12.10.3 Body Infections & Inflammations
12.10.4 Bone Fracture & Infections
12.10.5 Gall Bladder & Bile Duct Functions
12.10.6 Gastrointestinal Bleeding
12.10.7 Tumor Localization
12.10.8 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnosis
13.6.2 Prognosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Heart Blood Flow Functions
13.10.2 Differential Lung Function
13.10.3 Body Infections & Inflammations
13.10.4 Bone Fracture & Infections
13.10.5 Gall Bladder & Bile Duct Functions
13.10.6 Gastrointestinal Bleeding
13.10.7 Tumor Localization
13.10.8 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radionuclide Scanning Services Market: Competitive Dashboard
14.2 Global Radionuclide Scanning Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sonic Healthcare
14.3.2 Aditya Birla Health Services
14.3.3 Alliance Medical
